Paper Details

  1. Home
  2. Paper Details

Re-treatment of patients with hepatitis C who failed to respond (nonresponders) to previous treatment.

Author: ChkhartishviliN I, GogichaishviliSh Sh, SakandelidzeTs G, SharvadzeL G, ZhamutashviliM T

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study investigated the effectiveness of retreatment with pegylated interferon and ribavirin in patients with hepatitis C who had previously failed treatment. The study found that retreatment was effective in patients who had experienced a relapse (HCV RNA became undetectable during treatment but returned after treatment stopped). Retreatment was less effective in those who didn't respond to the initial treatment, including those with persistent infection or whose infection returned during treatment. The study also found that retreatment was more effective for those with non-genotype 1 hepatitis C compared to genotype 1.
Paper Details　
Original Abstract of the Article :
The aim of four-year follow up study was evaluation of re-treatment efficacy of antiviral therapy in patients with hepatitis C who failed to respond (non responders) to previous therapy. Study enrolled 29 patients, aged 21-59 with HCV infection (15 had HCV genotype 1, and 14 had HCV non-genotype1), ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/19202222

データ提供：米国国立医学図書館（NLM）

Retreatment for Hepatitis C: Navigating a Challenging Terrain

The world of [hepatitis C (HCV) treatment] is a complex landscape, with a history of navigating challenging terrain. This research examines the effectiveness of retreatment with pegylated interferon and ribavirin in patients who failed to respond to previous treatment. The authors conducted a four-year follow-up study, seeking a clearer path through this intricate landscape.

Retreatment Effectiveness: A Mixed Landscape

The study found that retreatment was more effective in patients who relapsed after initial treatment. However, retreatment was less effective in patients who were non-responders, partial responders, or breakthrough non-responders, especially in those with HCV genotype 1. This is like encountering different terrains in the desert – some areas are more hospitable to retreatment, while others present greater challenges.

Navigating the Desert of HCV Treatment: Seeking Effective Strategies

This research provides valuable insights into the complexities of HCV treatment. The study underscores the importance of considering the type of response to initial treatment, the HCV genotype, and the severity of the disease when deciding whether to pursue retreatment. This is like adapting your strategies to the terrain, ensuring a more effective and successful journey through the desert of HCV infection.

Dr. Camel's Conclusion

This research highlights the ongoing quest for effective treatments for HCV infection. The study underscores the need for individualized approaches, considering the unique characteristics of each patient and the specific challenges presented by HCV infection. The desert of HCV research continues to hold many secrets, but this study offers valuable insights into the potential of retreatment and the need for ongoing research to improve treatment strategies.

Date :
  1. Date Completed 2009-06-02
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

19202222

DOI: Digital Object Identifier

19202222

Related Literature

Article Analysis
・Effective treatment of hepatitis c
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.